Pharsight

Drugs that contain Omeprazole

1. Omeprazole patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023391 DEXCEL PHARMA Stable benzimidazole formulation
Aug, 2025

(1 year, 3 months from now)

Market Authorisation Date: 04 December, 2007

Treatment: NA

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

OMEPRAZOLE family patents

Family Patents

2. Omeprazole patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10835488 DEXCEL Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(12 years from now)

US10076494 DEXCEL Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(12 years from now)

Market Authorisation Date: 05 July, 2017

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage

OMEPRAZOLE family patents

Family Patents

3. Prilosec patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6191148 ASTRAZENECA Omerazole process and compositions thereof
Oct, 2018

(5 years ago)

US6147103 ASTRAZENECA Omeprazole process and compositions thereof
Oct, 2018

(5 years ago)

US6166213 ASTRAZENECA Omeprazole process and compositions thereof
Oct, 2018

(5 years ago)

US6150380 ASTRAZENECA Crystalline form of omeprazole
Nov, 2018

(5 years ago)

US6147103

(Pediatric)

ASTRAZENECA Omeprazole process and compositions thereof
Apr, 2019

(5 years ago)

US6191148

(Pediatric)

ASTRAZENECA Omerazole process and compositions thereof
Apr, 2019

(5 years ago)

US6166213

(Pediatric)

ASTRAZENECA Omeprazole process and compositions thereof
Apr, 2019

(5 years ago)

US6150380

(Pediatric)

ASTRAZENECA Crystalline form of omeprazole
May, 2019

(4 years ago)

Market Authorisation Date: 05 October, 1995

Treatment: NA

Dosage: CAPSULE, DELAYED REL PELLETS;ORAL

How can I launch a generic of PRILOSEC before it's drug patent expiration?
More Information on Dosage

PRILOSEC family patents

Family Patents